Charles River Laboratories International (CRL) Earnings Date, Estimates & Call Transcripts $191.56 +2.23 (+1.18%) (As of 12:19 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Charles River Laboratories International Latest Earnings SummaryActual EPS (Nov. 6) $2.59 Beat By $0.16 Consensus EPS (Nov. 6) $2.43 Charles River Laboratories International released Q3 2024 earnings on November 6, 2024, reporting an EPS of $2.59, which topped analysts' consensus estimates of $2.43 by $0.16. Quarterly revenue fell 1.6% year-over-year to $1.01 billion, above the consensus estimate of $975.99 million. With a trailing EPS of $7.99 and a P/E Ratio of 23.76, Charles River Laboratories International's earnings are expected to grow 1.87% next year, from $10.18 to $10.37 per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K FilingPowered by Get Charles River Laboratories International Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Charles River Laboratories International and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCRL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CRL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Charles River Laboratories International Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$2.05$2.73$2.39 Q2 20242$2.38$2.68$2.53 Q3 20242$2.43$3.09$2.76 Q4 20242$2.46$2.47$2.47 FY 20248$9.32$10.97$10.15 Q1 20252$2.41$2.42$2.42 Q2 20252$2.44$2.74$2.59 Q3 20252$2.59$3.21$2.90 Q4 20252$2.62$2.85$2.74 FY 20258$10.06$11.22$10.64 Q1 20261$2.79$2.79$2.79 Q2 20261$2.88$2.88$2.88 Q3 20261$2.88$2.88$2.88 Charles River Laboratories International Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/6/2024Q3 2024$2.43$2.59+$0.16$3.85$975.99M$1.01B8/7/2024Q2 2024$2.39$2.80+$0.41$3.86$1.03B$1.03B5/9/2024Q1 2024$2.05$2.27+$0.22$3.24$997.24M$1.01B2/14/2024Q4 2023$2.39$2.46+$0.07$1.30$991.25M$1.01B11/8/2023Q3 2023$2.35$2.72+$0.37$3.75$1.00B$1.03B8/9/2023Q2 2023$2.63$2.69+$0.06$3.49$1.05B$1.06B Get the Latest News and Ratings for CRL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023$2.59$2.78+$0.19$3.55$988.10M$1.03B2/22/2023Q4 2022$2.75$2.98+$0.23$2.31$1.04B$1.10B Charles River Laboratories International Earnings - Frequently Asked Questions When did Charles River Laboratories International announce their last quarterly earnings? Charles River Laboratories International (NYSE:CRL) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on CRL's earnings history. What guidance has Charles River Laboratories International issued on next quarter's earnings? Charles River Laboratories International issued an update on its FY 2024 earnings guidance on Wednesday, November, 6th. The company provided earnings per share (EPS) guidance of 10.100-10.300 for the period, compared to the consensus EPS estimate of 10.000. The company issued revenue guidance of $4.0 billion-$4.0 billion, compared to the consensus revenue estimate of $4.0 billion. Did Charles River Laboratories International beat their earnings estimates last quarter? In the previous quarter, Charles River Laboratories International (NYSE:CRL) reported $2.59 earnings per share (EPS) to beat the analysts' consensus estimate of $2.43 by $0.16. Learn more on analysts' earnings estimate vs. CRL's actual earnings. How can I listen to Charles River Laboratories International's earnings conference call? The conference call for Charles River Laboratories International's latest earnings report can be listened to online. Listen to Conference Call How can I read Charles River Laboratories International's conference call transcript? The conference call transcript for Charles River Laboratories International's latest earnings report can be read online. Read Transcript How can I view Charles River Laboratories International's earnings report? Charles River Laboratories International's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Charles River Laboratories International generate each year? Charles River Laboratories International (NYSE:CRL) has a recorded annual revenue of $4.06 billion. How much profit does Charles River Laboratories International generate each year? Charles River Laboratories International (NYSE:CRL) has a recorded net income of $474.62 million. CRL has generated $7.99 earnings per share over the last four quarters. What is Charles River Laboratories International's price-to-earnings ratio? Charles River Laboratories International (NYSE:CRL) has a trailing price-to-earnings ratio of 23.97 and a forward price-to-earnings ratio of 18.82. The price/earnings-to-growth ratio is 5. What is Charles River Laboratories International's EPS forecast for next year? Charles River Laboratories International's earnings are expected to grow from $10.18 per share to $10.37 per share in the next year, which is a 1.87% increase. More Earnings Resources from MarketBeat Related Companies MTD Earnings Results ILMN Earnings Results WAT Earnings Results TECH Earnings Results BIO Earnings Results BRKR Earnings Results PACB Earnings Results HBIO Earnings Results TMO Earnings Results A Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin This page (NYSE:CRL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRL Stock Alerts